About the AAMRI Gender Equality, Diversity and Inclusion Committee

About the AAMRI Gender Equality, Diversity and Inclusion Committee

On this page, find out about:

Meet the Committee members here.

To contact the committee, please get in touch with Dr Cath Latham, AAMRI’s Director of Policy (latham.c@aamri.org.au).

 

About the Committee

The AAMRI Committee for Gender Equity, Diversity and Inclusion (GEDI) was established by the AAMRI Board in July 2020. While AAMRI has previously been active in this area, AAMRI’s activities will now be coordinated through this dedicated Committee of experts.

Committee members are researchers and professional staff based at medical research institutes with experience, insight and passion for gender equality, diversity and inclusion in medical research through their work and lived experiences.

Chaired by Professor Maxine Morand, AAMRI Board Director and Chair of the Peter MacCallum Cancer Centre, the Committee is dedicated to advancing gender equity for the health and medical research sector through a diversity and inclusion lens.

In 2021, the Committee developed AAMRI’s five year GEDI Strategy and Action Plan in consultation with AAMRI members, setting out the way forward in four priorities areas for action. Download the AAMRI GEDI Strategy and Action Plan.

Meet the Committee members here.

 

Statement of Purpose

The AAMRI Gender Equity, Diversity and Inclusion Committee seeks to:

  • Identify and prioritise areas for action to better retain, promote and attract women in medical research. The Committee will consider existing systemic GEDI issues in medical research as well as the impact of major disruptions [1] in exacerbating existing inequalities.
  • Ensure that their actions and recommendations are intersectional and inclusive of all women.
  • Represent and advocate for medical research institutes on GEDI issues to key stakeholders including government
  • Advance GEDI for medical research institutes by providing guidance on best practice and actionable recommendations. This will complement existing efforts of other organisations working towards gender equality, diversity and inclusion in medical research and STEM more broadly.

 

The Committee Terms of Reference

  1. Recommend actions AAMRI can undertake to ensure gender equity, diversity and inclusion in all its activities
  2. Identify areas where AAMRI can most effectively advocate for change, working towards achieving gender equity, diversity and inclusion within the health and medical research sector
  3. Recommend actions medical research institutes can take to advance gender equality, diversity and inclusion in their organisations.

 

Four priority areas for action

The Committee has developed AAMRI’s GEDI Strategy and Action Plan in consultation with AAMRI’s member institutes (see the Strategy and Action Plan). The strategy focuses on actions for AAMRI and the MRI sector in four priority areas, which aim to advance gender equity in the health and medical research sector:

  1. Redefining measures of success and merit for greater diversity & inclusion
  2. Enabling mechanisms for gender equity in advancement and promotion
  3. Addressing sexual harassment and promoting safe workplaces
  4. Addressing inequities in health research

The impact of COVID-19 on existing inequities will be considered in these four priority areas by aiming to continue positive practices and mitigate negative impacts.

Read more about the four priority areas and the AAMRI GEDI Strategy and Action Plan here.

_____________________________________________

[1] For example, the impact of the COVID-19 pandemic.